Blog

Final science and recommendations reports are now available for the CADTH project on direct-acting antivirals for chronic hepatitis C genotype 1. ...

Sucampo Pharmaceuticals, Inc.(Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that theUnited Kingdom's National Institute of Health and Care Excellence (NICE) has ...

[:content [\B \o \e \h \r \i \n \g \e \r \space \I \n \g \e \l \h \e \i \m \space \( \C \a \n \a \d \a \) \space \L \t \d \. \space \h \a \s \space \a \n \n \o \u \n \c \e \d \space \t \h \a \t \space \H \e \a \l \t \h \space \C \a \n \a \d \a \space \h \a \s \space \a \p \p \r \o \v \e \d \space \G \i \o \t \r \i \f \  \( \a \f \a \t \i \n \i \b \) \space \t \a \b \l \e \t \s \space \f \o \r \space \o \r \a \l \space \u \s \e \, \space \a \s \space \a \space \n \e \w \space \t \r \e \a \t \m \e \n \t " ..."]]

[:content [\C \o \n \s \t \e \l \l \a \space \i \s \space \t \h \e \space \f \i \r \s \t \space \a \n \d \space \o \n \l \y \space \p \r \o \d \u \c \t \space \a \p \p \r \o \v \e \d \space \i \n \space \t \h \e \space \E \U \space \f \o \r \space \t \h \e \space \t \r \e \a \t \m \e \n \t \space \o \f \space \I \B \S \- \C \space \i \n \space \a \d \u \l \t \s \space \a \n \d \space \h \a \s " ..."]]

The agenda for the 17 December 2014 Transparency Commission meeting is now available. The Commission will consider the following medicines: ...

[:content [\2 \6 \space \F \e \b \r \u \a \r \y \space \2 \0 \1 \4 \space \- \  \N \I \C \E \space \h \a \s \space \p \u \b \l \i \s \h \e \d \  \f \i \n \a \l \space \g \u \i \d \a \n \c \e \  " ..."]]

[:content [\3 \1 \space \J \a \n \u \a \r \y \space \2 \0 \1 \4 \space \- \  \P \H \A \R \M \A \C \space \h \a \s \space \r \e \s \o \l \v \e \d \space \t \o \space \a \w \a \r \d \space \t \e \n \d \e \r \s \space \f \o \r \space \S \o \l \e \space \S \u \b \s \i \d \i \s \e \d \space \S \u \p \p \l \y \space \S \t \a \t \u \s \space \a \n \d \space \H \o \s \p \i \t \a \l \space \S \u \p \p \l \y \space \S \t \a \t \u \s \space \f \o \r \space \s \o \m \e " ..."]]

[:content [\1 \3 \space \J \a \n \u \a \r \y \space \2 \0 \1 \4 \  \- \space \N \o \v \a \r \t \i \s \space \P \h \a \r \m \a \c \e \u \t \i \c \a \l \s \space \C \a \n \a \d \a \space \I \n \c \. \space \a \n \n \o \u \n \c \e \d \space \t \o \d \a \y \space \t \h \a \t \space \H \e \a \l \t \h \space \C \a \n \a \d \a \space \h \a \s \space \a \p \p \r \o \v \e \d \space \t \h \e \space \u \s \e \space \o \f \space \l \o \n \g \- \t \e \r \m \space \o \n \c \e \- \d \a \i \l \y \space \d \u \a \l " ..."]]

The drug combination of ledipasvir and sofosbuvir (trade name Harvoni) has been available since November 2014 for the treatment of ...

Actelion Ltd today announced the approval of Opsumit (macitentan) for the treatment of pulmonary arterial hypertension (PAH) by the Therapeutic ...

DHBs are expected to start making further savings in cardiac medical devices, after PHARMAC extended the range of products it ...

CADTH has received notice of a pending submission from Medunik Canada for Pheburane (sodium phenylbutyrate). For information about the patient input ...

Australian biopharmaceutical company Specialised Therapeutics Australia (STA) is pleased to announce Abraxane (nanoparticle albumin-bound paclitaxel) in combination with gemcitabine, will be ...

[:content [\7 \space \M \a \r \c \h \space \2 \0 \1 \4 \space \- \  \F \r \o \m \space \1 \space \A \p \r \i \l \space \2 \0 \1 \4 \, \space \t \h \e \space \G \o \v \e \r \n \m \e \n \t \space \w \i \l \l \space \i \m \p \l \e \m \e \n \t \space \a \space \n \e \w \space \s \t \r \e \a \m \l \i \n \e \d \space \p \r \o \c \e \s \s \space \t \o \space \r \e \d \u \c \e \space \t \h \e \space \t \i \m \e \space \t \a \k \e \n " ..."]]